Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Haemophilus influenzae type b antigen assay (procedure) |
Has measured component |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Haemophilus influenzae type b antigen assay (procedure) |
Component |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Haemophilus influenzae type b antigen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Clostridium tetani and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) |
Is a |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vaccine product containing Haemophilus influenzae type B and Hepatitis B virus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens only paediatric vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Haemophilus influenzae type b antigen only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Haemophilus influenzae type b (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |